Pharmaceutical and Medical Device
King & Spalding’s Pharmaceutical & Medical Device practice is consistently recognized as among the best in the nation. Our knowledge of the industry, combined with our broad capabilities and a deep bench of first-chair trial attorneys, allow us to handle any aspect of drug and device litigation, from early case assessment, through discovery, and on to trial and exit strategies.
January 13, 2025
FDA Finalizes Guidance on Scientific Information on Unapproved Uses (SIUU)
January 6, 2025
FDA Issues Draft Guidance on Accelerated Approval Focused on How the Agency Will Implement New Authorities
December 13, 2024
FDA Publishes Final Predetermined Change Control Plan Guidance for AI-Enabled Device Software Functions
February 27, 2025
Kristen Fournier, Matthew Bush, Cason Hewgley, and Paige Tenkhoff defeat a motion to dismiss on behalf of Johnson & Johnson subsidiary LLT Management
February 3, 2025
CVN Ranks King & Spalding’s Johnson & Johnson Cosmetic Talc Trial as 3rd Most Impressive Defense Verdict of 2024
February 24, 2025
King & Spalding Secures Another Victory for Boehringer Ingelheim in Zantac-Related Retrial
February 7, 2025
King & Spalding Defeats Motion to Dismiss in Trade Libel Case